NEU neuren pharmaceuticals limited

Ann: 2024 results - A$166m comprehensive income for shareholders, page-5

  1. 34,529 Posts.
    lightbulb Created with Sketch. 9499
    $359m pro-forma cash! That's after tax amount.
    2025 annual royalties will be around $65m.
    Europe sales may come as early as Q2, 2025, expected to be approved in Q1, 2026.
    Canada sales in Q3,2025.
    Annual royalties for next year, is likely to reach $100m, imo.

    Cash burn rate might not as high as I expected,
    2024 R&D: $33m
    Corporate & administrative: $4.7m
    Total: $37.7m for the year.
    Last edited by 8horse: 28/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.80
Change
0.320(1.94%)
Mkt cap ! $2.109B
Open High Low Value Volume
$16.65 $16.90 $16.33 $3.834M 228.8K

Buyers (Bids)

No. Vol. Price($)
3 57 $16.80
 

Sellers (Offers)

Price($) Vol. No.
$16.82 551 6
View Market Depth
Last trade - 14.37pm 29/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.